| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $534K | +12.2% | +68.5% |
| Cost of Revenue | $4.1M | +44.9% | +433.7% |
| R&D Expense | $6.2M | +1.4% | +142.8% |
| SG&A Expense | $16.9M | -8.8% | +87.0% |
| Operating Income | -$29.2M | +79.5% | -113.6% |
| Pre-tax Income | -$38.3M | +73.3% | -401.7% |
| Income Tax | -$3.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.1M | +30.1% | — |
| Accounts Receivable | $1.6M | +74.1% | — |
| Inventory | $6.4M | -3.3% | +126.8% |
| Current Assets | $32.3M | +52.6% | +52.0% |
| Total Assets | $556.5M | +0.1% | +898.6% |
| Current Liabilities | $82.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$56.3M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$4.1M | — | — |
| Financing Cash Flow | $63.3M | — | — |
| Free Cash Flow | -$57.7M | — | — |
| -62.3% |
| — |
| Net Income | -$28.3M | +66.4% | -1181.4% |
| EPS (Basic) | -$0.51 | +68.1% | +45.7% |
| EPS (Diluted) | -$0.51 | +68.1% | +45.7% |
| +14.0% |
| +98.3% |
| Long-term Debt | $29.5M | +76.2% | +98.0% |
| Total Liabilities | $149.9M | +15.4% | +170.4% |
| Stockholders' Equity | $190.8M | -12.7% | +955.2% |